US 2007/0191262 A1Published application

Cancer Therapy and Prevention Based on Modulation of Complement activity

AssigneeUniversity of Iowa Research Foundation

InventorsDoina Racila, Emilian Racila, George Weiner

Life of this patent

Estimating the term…

Abstract

The present invention encompasses methods for inhibiting cancer, but in particular for inhibiting metastasis, by administering to a cancer patient an inhibitor of the complement cascade.

Claims24

Dependent claims

A method of inhibiting cancer comprising contacting a patient having cancer with a first inhibitor of the complement cascade.

Dependencies are inferred from the claim text.

Facts

Application: 11/560,155Filed 15 Nov 2006
Priority: 15 Nov 2005
Published: 16 Aug 2007
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

C12Q 1/6886
For diseases caused by alterations of genetic material: for cancer
A61K 31/00
Medicinal preparations containing organic active ingredients
C12Q 2600/106
Oligonucleotides characterized by their use: pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
C12Q 2600/156
Oligonucleotides characterized by their use: polymorphic or mutational markers

Family

Application60/736,667Us provisional application · filed 15 Nov 2005
US 2007/0191262 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results